Premier Biomedical Inc (BIEI) Return on Investment ROI from the fourth quarter of 2019 to fourth quarter of 2018 and for the year 2019, average high and low, overall ranking from Dec 31 2019 to Dec 31 2018 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Premier Biomedical Inc  (BIEI)


Premier Biomedical Inc's ROI from its fourth quarter of 2019 to the fourth quarter of 2018 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Premier Biomedical Inc's ROI in the fourth quarter of 2019?
Due to the stockholders deficit and subsequent negative measured investments, it was not possible to calculate Premier Biomedical Inc's return on investment (ROI) in its fourth quarter of 2019

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Dec 31 2019)
IV. Quarter		 (Sep 30 2019)
III. Quarter		 (Jun 30 2019)
II. Quarter		 (Mar 31 2019)
I. Quarter		 (Dec 31 2018)
IV. Quarter
Y / Y Investment Change TTM - - - - -
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 0 0 0 0 0
Return On Investment (TTM) - - - - -
BIEI's Overall Ranking # # # # #
Seq. Investment Change TTM - - - - -
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions 0 -1 -1 -1 0

BIEI Company Profile >> Back to BIEI Roi Comparisons >> See Annual BIEI Return On Investment



Return On Investment BIEI's Ranking
Within: No.
Industry #
Sector #
Overall #

Return On Investment Statistics
High Average Low
0 %
0 %
0 %
 







Financial Statements
Premier Biomedical Inc's IV. Quarter Investments $ 0 Millions BIEI's Balance sheet
Premier Biomedical Inc's IV. Quarter Income $ 0 Millions Quarterly BIEI's Income Statement
BIEI's Income by Division See BIEI's Income by Division


BIEI Annual Return On Investment (Dec 31 2019)
2019		 (Dec 31 2018)
2018		 (Dec 31 2017)
2017		 (Dec 31 2016)
2016		 (Dec 31 2015)
2015
Total Investments in Millions 0 0 0 0 0
Y / Y Investment Growth - - - - -
Net Income in Millions 0 0 -4 -2 -3
Y / Y Net Income Growth - - - - -
Annual Return On Investment - - - - -


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Biotechnology & Pharmaceuticals Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
BIEI's Roi Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for BIEI's Competitors
Subscribers only: Roi for Premier Biomedical Inc's Suppliers
Subscribers only: Return On Investment for BIEI's Customers

Other Ratios
BIEI's Roa BIEI's Inventory Turnover Ratio BIEI's Growth Rates BIEI's Dividend Statistics
BIEI's Profitability Ratios BIEI's Asset Turnover Ratio BIEI's Dividend Growth
BIEI's Roe BIEI's Valuation Ratios BIEI's Financial Strength Ratios BIEI's Dividend Payout Ratio



Companies with similar Return On Investment at Dec 31 2019, within Healthcare Sector ROI
Progyny Inc   282.27 %
Check Cap Ltd  208.78 %
Quoin Pharmaceuticals Ltd   166.78 %
Semler Scientific inc   152.40 %
Tenax Therapeutics Inc   113.26 %
Rapt Therapeutics Inc   98.39 %
Altamira Therapeutics Ltd   89.97 %
Morphic Holding inc   84.53 %
Jounce Therapeutics inc   69.85 %
Orgenesis Inc   68.81 %
Molecular Templates Inc   65.27 %
Novo Nordisk A  58.34 %
Surgalign Holdings Inc   51.94 %
Zynex inc   50.39 %
Palatin Technologies Inc   48.31 %
Cnbx Pharmaceuticals Inc   47.76 %
Nrc Health  47.24 %
Catalyst Pharmaceuticals Inc   45.03 %
Opiant Pharmaceuticals Inc   44.81 %
Lexicon Pharmaceuticals Inc   43.63 %
Coherus Oncology inc   41.66 %
Lifevantage Corp  40.71 %
Remedent Inc   39.46 %
Oramed Pharmaceuticals Inc  39.46 %
Ligand Pharmaceuticals Incorporated  38.92 %
Aveo Pharmaceuticals Inc   38.01 %
Integrated Biopharma Inc  34.06 %
Arena Pharmaceuticals Inc   32.53 %
Vanda Pharmaceuticals Inc   31.98 %
Align Technology inc   31.31 %

Date modified: 2026-09-08T15:09:57+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.